CoreCap Advisors »

Cadrenal Therapeutics shares owned by CoreCap Advisors

Quarter-by-quarter ownership of Cadrenal Therapeutics shares owned by CoreCap Advisors from 13F filings

Historical chart of CoreCap Advisors investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by CoreCap Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by CoreCap Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.3k 1.3k 3.34

More positions owned by CoreCap Advisors

Vanguard Total Stock Market Etf Etf (VTI)
State Street Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
State Street Technology Select Sector Spdr Etf Etf (XLK)
Vanguard Total Bond Market Etf Etf (BND)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard S&p 500 Etf Etf (VOO)
Schwab U.s. Small-cap Etf Etf (SCHA)
Apple Stock (AAPL)
Goldman Sachs Marketbeta U.s. Equity Etf Etf (GSUS)
Vanguard Value Etf Etf (VTV)
Nvidia Corporation Stock (NVDA)
State Street Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Ishares Core S&p 500 Etf Etf (IVV)
State Street Spdr S&p 500 Etf Etf (SPY)

View all positions for CoreCap Advisors

Top funds holding Cadrenal Therapeutics

CoreCap Advisors
Harbour Investments
Farther Finance Advisors
Caldwell Sutter Capital

View all funds holding Cadrenal Therapeutics